Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases.
Cambieri C, Marenco M, Colasanti T, Mancone C, Corsi A, Riminucci M, Libonati L, Moret F, Chimenti C, Lambiase A, Conti F, Garibaldi M, Inghilleri M, Ceccanti M. Cambieri C, et al. Among authors: ceccanti m. Curr Neuropharmacol. 2023;21(12):2543-2549. doi: 10.2174/1570159X21666230623094710. Curr Neuropharmacol. 2023. PMID: 37357518 Free PMC article.
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models.
Margotta C, Fabbrizio P, Ceccanti M, Cambieri C, Ruffolo G, D'Agostino J, Trolese MC, Cifelli P, Alfano V, Laurini C, Scaricamazza S, Ferri A, Sorarù G, Palma E, Inghilleri M, Bendotti C, Nardo G. Margotta C, et al. Among authors: ceccanti m. Inflamm Regen. 2023 Mar 9;43(1):19. doi: 10.1186/s41232-023-00270-w. Inflamm Regen. 2023. PMID: 36895050 Free PMC article.
Correction: Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models.
Margotta C, Fabbrizio P, Ceccanti M, Cambieri C, Rufolo G, D'Agostino J, Trolese MC, Cifelli P, Alfano V, Laurini C, Scaricamazza S, Ferri A, Sorarù G, Palma E, Inghilleri M, Bendotti C, Nardo G. Margotta C, et al. Among authors: ceccanti m. Inflamm Regen. 2023 Apr 19;43(1):25. doi: 10.1186/s41232-023-00276-4. Inflamm Regen. 2023. PMID: 37072876 Free PMC article. No abstract available.
Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO).
Leonardi L, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Lauletta A, Rossini E, Tufano L, Ceccanti M, Esposito N, Falco P, di Pietro G, Truini A, Galosi E. Leonardi L, et al. Among authors: ceccanti m. J Peripher Nerv Syst. 2023 Sep;28(3):390-397. doi: 10.1111/jns.12586. Epub 2023 Aug 16. J Peripher Nerv Syst. 2023. PMID: 37535421
Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy.
Moret F, Spada E, Ceccanti M, Libonati L, D'Andrea E, Villano U, Madonna E, Chionne P, Carocci A, Pisani G, Fionda L, Antonini G, Petrucci A, Bruni R, Ciccaglione AR, Taliani G, Rivano Capparuccia M, Nobile-Orazio E, Inghilleri M, Cambieri C. Moret F, et al. Among authors: ceccanti m. J Neurol Sci. 2024 Apr 15;459:122959. doi: 10.1016/j.jns.2024.122959. Epub 2024 Mar 12. J Neurol Sci. 2024. PMID: 38490091 Free article.
213 results